Developing Antidepressants that Build the Brain: Dr. Mary Kay Lobo

For this Brain Waves interview, One Mind President Brandon Staglin spoke with Mary Kay Lobo, PhD, a 2016 One Mind / Janssen Rising Star Translational Research Award winner, on her innovative progress toward developing safer, more effective depression medications.

Dr. Lobo is Associate Professor of Anatomy, Neurobiology and Psychiatry at University of Maryland School of Medicine, and her work has appeared in numerous recent news articles. She is an expert in the basic science of depression and addiction, and is also engaging to talk with.

Learn more about Dr. Lobo’s research on her Research Updates page.

Visit Dr. Lobo’s lab webpage at the University of Maryland

Learn more about depression and the other research One Mind is funding here.

16 thoughts on “Antidepressants that Build the Brain

    1. This is a great question. Most of our works is in males since our stress model can only be performed in males. However, some of our data indicates that the molecules we are studying can underlie depressive-like behavior in both males and females. We have recently established a female stress model and will start testing the inhibitors of these molecules in females.

  1. Hi Everyone! Thank you to the audience for watching.
    And thank you for the comments and questions. Please post more questions. I am happy to answer them all. – Mary Kay

Comments are closed.